指南与共识重症综合管理与镇静镇痛

COVID-19相关临床研究调整的经验、认知与建议

Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.
指南 / 共识 · J Natl Compr Canc Netw · 2020-10-07
一句话结论临床研究专业人员认为COVID-19相关临床试验调整对患者安全、疗效及多方沟通有积极影响,超过90%认为应继续。

该研究对Harold C. Simmons综合癌症中心临床研究办公室人员发放匿名调查,评估对COVID-19相关临床试验调整的经验、认知与建议。109人中94人(87%)回应,58%有>5年临床研究经验,56%亲身经历过COVID-19相关调整。受访者认为这些调整对患者安全、治疗效果、患者与员工体验及与患者、研究者、申办方的沟通有积极影响,超过90%认为积极调整应在COVID-19后继续。对远程知情同意、远程医疗、治疗药物配送、院外诊断和远程监查,有特定调整亲身经历者和>5年专业经验者更倾向于建议继续,远程医疗(P=.04)和治疗药物配送(P=.02)差异有统计学意义。

要点

  • 94/109(87%)临床研究专业人员回应调查,58%有>5年临床研究经验,56%亲身经历COVID-19相关调整。
  • 受访者认为COVID-19相关调整对患者安全、治疗效果、患者与员工体验及多方沟通有积极影响。
  • 超过90%受访者认为积极调整应在COVID-19后继续。
  • 对远程医疗(P=.04)和治疗药物配送(P=.02),有亲身经历者及>5年经验者更倾向建议继续,差异有统计学意义。
  • 远程知情同意、院外诊断和远程监查方面,有亲身经历者及>5年经验者建议继续的比例在数值上更高。

适用人群与场景

  • Harold C. Simmons综合癌症中心临床研究办公室人员,共联系109人,94人回应。

研究设计与关键结果

  • 研究类型:匿名调查研究,单中心,样本量94人(联系109人,回应率87%)。
  • 58%受访者有>5年临床研究专业经验,56%亲身经历过COVID-19相关研究调整。
  • 受访者认为COVID-19相关调整对患者安全、治疗效果、患者与员工体验及与患者、研究者、申办方的沟通有积极影响。
  • 超过90%受访者认为积极调整应在COVID-19后继续。
  • 对远程知情同意、远程医疗、治疗药物配送、院外诊断和远程监查,有特定调整亲身经历者和>5年专业经验者建议继续的比例在数值上更高。
  • 远程医疗方面差异有统计学意义(P=.04),治疗药物配送方面差异有统计学意义(P=.02)。

证据类型、等级与局限

  • 证据类型:匿名调查研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 临床研究专业人员认为COVID-19相关临床试验调整对研究实施的多个方面有积极影响。
  • 超过90%受访者认为积极调整应在COVID-19后继续。
  • 有特定调整亲身经历者和>5年专业经验者更倾向于建议继续远程医疗(P=.04)和治疗药物配送(P=.02)调整。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: During the COVID-19 public health emergency, the FDA and NIH altered clinical trial requirements to protect participants and manage study conduct. Given their detailed knowledge of research protocols and regular contact with patients, clinicians, and sponsors, clinical research professionals offer important perspectives on these changes.

METHODS: We developed and distributed an anonymous survey assessing COVID-19-related clinical trial adjustment experiences, perceptions, and recommendations to Clinical Research Office personnel at the Harold C. Simmons Comprehensive Cancer Center. Responses were compared using the Fisher exact test.

RESULTS: A total of 94 of 109 contacted research personnel (87%) responded. Among these individuals, 58% had >5 years' professional experience in clinical research, and 56% had personal experience with a COVID-19-related change. Respondents perceived that these changes had a positive impact on patient safety; treatment efficacy; patient and staff experience; and communication with patients, investigators, and sponsors. More than 90% felt that positive changes should be continued after COVID-19. For remote consent, telehealth, therapy shipment, off-site diagnostics, and remote monitoring, individuals with personal experience with the specific change and individuals with >5 years' professional experience were numerically more likely to recommend continuing the adjustment, and these differences were significant for telehealth (P=.04) and therapy shipment (P=.02).

CONCLUSIONS: Clinical research professionals perceive that COVID-19-related clinical trial adjustments positively impact multiple aspects of study conduct. Those with greatest experience-both specific to COVID-19-related changes and more generally-are more likely to recommend that these adjustments continue in the future.

来源:J Natl Compr Canc Netw,查看原文。版权归原作者所有。

参考来源

  1. Gerber DE, Sheffield TY, Beg MS, et al. Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments. J Natl Compr Canc Netw. 2020. PMID: 33027755. doi:10.6004/jnccn.2020.7643

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。